Traditional Diagnostic Support Systems Surpass Generative AI in Disease Diagnosis

Traditional expert systems like DXplain continue to outperform generative AI models in disease diagnosis, with hybrid approaches promising further advancements in clinical decision support.
In the evolving landscape of medical diagnostics, traditional expert systems have demonstrated superior performance compared to generative AI models. Historically, diagnostic decision support systems (DDSSs), such as the well-established DXplain developed by Massachusetts General Hospital in 1984, have utilized extensive databases of disease profiles and clinical findings to assist clinicians in identifying potential diagnoses. These systems have been integral in augmenting medical decision-making by recalling relevant information rapidly, reducing cognitive load, and minimizing diagnostic errors.
With recent advances in artificial intelligence, particularly the advent of large language models (LLMs) like ChatGPT and Gemini, researchers at MGH’s Laboratory of Computer Science undertook a comparative study to evaluate their diagnostic accuracy against DXplain. The study involved 36 diverse patient cases across different demographic groups, assessing each system’s ability to recommend correct diagnoses both with and without laboratory data.
The findings revealed that DXplain had a slight edge, correctly identifying diagnoses 72% of the time with lab data and 56% without, outperforming LLMs which achieved 64% and 42%, respectively. Nonetheless, LLMs performed commendably and showed potential when integrated with traditional systems. Experts suggest that combining the explanatory strengths of DDSSs with the linguistic and narrative capabilities of modern LLMs could significantly enhance clinical diagnostic support and improve patient outcomes.
Dr. Edward Hoffer emphasized the continued importance of expert systems, highlighting their bias-free recall of medical knowledge and unbiased reasoning. Meanwhile, Mitchell Feldman underscored the promise of hybrid approaches, where LLMs can extract clinical findings from narrative text for input into DDSSs. This synergy could overcome limitations inherent in each individual technology and facilitate more accurate, rapid diagnosis in complex cases.
Overall, while generative AI models are advancing, traditional diagnostic systems remain valuable tools, and their integration with AI could represent the future of clinical decision support systems, ultimately leading to better diagnostic accuracy and patient care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
UK Implements Ban on Disposable Vapes to Protect Public Health
The UK has implemented a nationwide ban on disposable vapes to protect public health and the environment, targeting youth nicotine use and reducing vape waste.
The Role of Balanced Excitatory and Inhibitory Neurons in Brain Memory Processing
New insights reveal that the balance between excitatory and inhibitory neurons is crucial for efficient memory storage and processing in the brain, advancing our understanding of neural network dynamics.
New Biomarkers May Predict Failure of Treatment in Metastatic Prostate Cancer
Blood-based biomarkers such as platelets, CRP, and chromogranin A may help predict treatment failure in metastatic prostate cancer, enabling personalized therapeutic strategies.
Understanding Breast Cancer Risks and Outcomes in Aboriginal and Torres Strait Islander Women
This article explores the disparities in breast cancer incidence, diagnosis, and survival outcomes among Aboriginal and Torres Strait Islander women, emphasizing the need for culturally safe healthcare and targeted interventions.